The Neuroscience of Antidepressants: Monoamine Hypothesis and Beyond

There’s a lot of talk about the monoamine hypothesis of Depression, which is the theory that a reduced level of serotonin, dopamine and norepinephrine in the central nervous system is what causes symptoms of depression, but is it the cause?

In this episode we’ll find out what the evidence is, and what treatments work based on that hypothesis, and how they relate to the drugs that are currently on the market to treat symptoms of Depression. In the next episode we'll go into more detail about the glutamatergic system and how these drugs interact with the brain, and potentially new treatments that could potentially reverse the negative side effects of some of the existing treatments.

LINKS:

• Listen to Part 2 of the Neuroscience of Antidepressants: The Glutamate Hypothesis at https://pod.fo/e/219f62 . 
• Listen to my episode on Ketamine as a treatment for depression here https://bit.ly/Dyfm-ketamine.
• Join the DYFM Facebook Group https://bit.ly/dyfm-group .
• Follow @dyfmpodcast on IG 
• Follow @alexispredez on IG  
• Follow @listnrentertainment on IG 

CREDITS

Host: Alexis Fernandez       
Executive Producer & Editor: Elise Cooper
Digital Producer: Zoe Panaretos
DYFM Social Producer: Shania Magua
Managing Producer: Sam Cavanagh 

Learn more about your ad choices. Visit megaphone.fm/adchoices